MicroRNAs as a clue to overcome breast cancer treatment resistance

por Garrido-Cano, Iris, Pattanayak, Birlipta, Adam-Artigues, Anna, Lameirinhas, Ana, Torres-Ruiz, Sandra, Tormo, Eduardo, Cervera, Raimundo, Eroles, Pilar
Publicado 2021

Solid Tumor Opioid Receptor Expression and Oncologic Outcomes: Analysis of the Cancer Genome Atlas and Genotype Tissue Expression Project

por Belltall, Amparo, Zúñiga-Trejos, Sheila, Garrido-Cano, Iris, Eroles, Pilar, Argente-Navarro, Maria Pilar, Buggy, Donal J., Díaz-Cambronero, Oscar, Mazzinari, Guido
Publicado 2022

Opioid Receptor Expression in Colorectal Cancer: A Nested Matched Case-Control Study

por Belltall, Amparo, Mazzinari, Guido, Garrido-Cano, Iris, Giner, Francisco, Marí, Anabel Marqués, Eroles, Pilar, Argente-Navarro, María Pilar, Cata, Juan Pablo, Diaz-Cambronero, Oscar
Publicado 2022

Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective

por Hernando, Cristina, Ortega-Morillo, Belén, Tapia, Marta, Moragón, Santiago, Martínez, María Teresa, Eroles, Pilar, Garrido-Cano, Iris, Adam-Artigues, Anna, Lluch, Ana, Bermejo, Begoña, Cejalvo, Juan Miguel
Publicado 2021

Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy

por Garrido-Cano, Iris, Adam-Artigues, Anna, Lameirinhas, Ana, Blandez, Juan F., Candela-Noguera, Vicente, Lluch, Ana, Bermejo, Begoña, Sancenón, Felix, Cejalvo, Juan Miguel, Martínez-Máñez, Ramón, Eroles, Pilar
Publicado 2023

Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies

por Tapia, Marta, Hernando, Cristina, Martínez, María Teresa, Burgués, Octavio, Tebar-Sánchez, Cristina, Lameirinhas, Ana, Ágreda-Roca, Anna, Torres-Ruiz, Sandra, Garrido-Cano, Iris, Lluch, Ana, Bermejo, Begoña, Eroles, Pilar
Publicado 2023

High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer

por Torres-Ruiz, Sandra, Tormo, Eduardo, Garrido-Cano, Iris, Lameirinhas, Ana, Rojo, Federico, Madoz-Gúrpide, Juan, Burgués, Octavio, Hernando, Cristina, Bermejo, Begoña, Martínez, María Teresa, Lluch, Ana, Cejalvo, Juan Miguel, Eroles, Pilar
Publicado 2023

Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer

por Garrido-Cano, Iris, Constâncio, Vera, Adam-Artigues, Anna, Lameirinhas, Ana, Simón, Soraya, Ortega, Belen, Martínez, María Teresa, Hernando, Cristina, Bermejo, Begoña, Lluch, Ana, Lopes, Paula, Henrique, Rui, Jerónimo, Carmen, Cejalvo, Juan Miguel, Eroles, Pilar
Publicado 2020

miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies

por Garrido‐Cano, Iris, Adam‐Artigues, Anna, Lameirinhas, Ana, Blandez, Juan F., Candela‐Noguera, Vicente, Rojo, Federico, Zazo, Sandra, Madoz‐Gúrpide, Juan, Lluch, Ana, Bermejo, Begoña, Sancenón, Felix, Cejalvo, Juan Miguel, Martínez‐Máñez, Ramón, Eroles, Pilar
Publicado 2022

MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma

por Pattanayak, Birlipta, Garrido-Cano, Iris, Adam-Artigues, Anna, Tormo, Eduardo, Pineda, Begoña, Cabello, Paula, Alonso, Elisa, Bermejo, Begoña, Hernando, Cristina, Martínez, María Teresa, Rovira, Ana, Albanell, Joan, Rojo, Federico, Burgués, Octavio, Cejalvo, Juan Miguel, Lluch, Ana, Eroles, Pilar
Publicado 2020

Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer

por Adam-Artigues, Anna, Garrido-Cano, Iris, Carbonell-Asins, Juan Antonio, Lameirinhas, Ana, Simón, Soraya, Ortega-Morillo, Belén, Martínez, María Teresa, Hernando, Cristina, Constâncio, Vera, Burgues, Octavio, Bermejo, Begoña, Henrique, Rui, Lluch, Ana, Jerónimo, Carmen, Eroles, Pilar, Cejalvo, Juan Miguel
Publicado 2021